+Compare
CPIX
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
23.81M

CPIX Cumberland Pharmaceuticals Forecast, Technical & Fundamental Analysis

a developer of branded prescription products

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for CPIX with price predictions
07:00 PM EST Dec 03, 2023

CPIX sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for CPIX moved above the 200-day moving average on November 01, 2023. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Momentum Indicator moved above the 0 level on November 30, 2023. You may want to consider a long position or call options on CPIX as a result. In of 123 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CPIX just turned positive on December 01, 2023. Looking at past instances where CPIX's MACD turned positive, the stock continued to rise in of 59 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CPIX advanced for three days, in of 210 cases, the price rose further within the following month. The odds of a continued upward trend are .

CPIX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

CPIX moved below its 50-day moving average on November 08, 2023 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CPIX crossed bearishly below the 50-day moving average on November 09, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CPIX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CPIX entered a downward trend on November 28, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CPIX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.677) is normal, around the industry mean (47.989). P/E Ratio (0.000) is within average values for comparable stocks, (60.542). CPIX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.883). CPIX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.027). P/S Ratio (0.630) is also within normal values, averaging (65.502).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CPIX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Intra-Cellular Therapies (NASDAQ:ITCI), Bausch Health Companies (NYSE:BHC), Tilray Brands (NASDAQ:TLRY), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 2.76B. The market cap for tickers in the group ranges from 246 to 82.08B. ZTS holds the highest valuation in this group at 82.08B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was 5%. For the same Industry, the average monthly price growth was 6%, and the average quarterly price growth was -5%. IXHL experienced the highest price growth at 565%, while CNTRF experienced the biggest fall at -49%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -10%. For the same stocks of the Industry, the average monthly volume growth was 96% and the average quarterly volume growth was 91%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 68
Price Growth Rating: 53
SMR Rating: 84
Profit Risk Rating: 92
Seasonality Score: 24 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I. Advisor
published General Information

General Information

a developer of branded prescription products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1600 West End Avenue
Phone
+1 615 255-0068
Employees
85
Web
https://www.cumberlandpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRAR1.370.03
+2.24%
Glimpse Group (The)
FAST60.970.15
+0.25%
Fastenal Company
PNM42.25N/A
N/A
PNM Resources
ESEA30.00-0.02
-0.07%
Euroseas Ltd
BASE20.02-0.15
-0.74%
Couchbase

CPIX and

Correlation & Price change

A.I.dvisor tells us that CPIX and PETQ have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CPIX and PETQ's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPIX
1D Price
Change %
CPIX100%
N/A
PETQ - CPIX
25%
Poorly correlated
-0.83%
LFCR - CPIX
25%
Poorly correlated
-1.36%
ANIP - CPIX
22%
Poorly correlated
-1.12%
SHOT - CPIX
22%
Poorly correlated
+15.45%
HROW - CPIX
21%
Poorly correlated
+3.87%
More

Groups containing CPIX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPIX
1D Price
Change %
CPIX100%
N/A
pharmaceuticals
(undefined stocks)
22%
Poorly correlated
+2.58%
Pharmaceuticals
(undefined stocks)
1%
Poorly correlated
+1.34%
Pharmaceuticals: Other
(undefined stocks)
1%
Poorly correlated
+1.67%